Douglas Galasko, Md - Introducing Our Longitudinal Study

Douglas Galasko, MD - Introducing Our Longitudinal Study

UCSD Shiley-Marcos ADRC

ADRC iPSC Core overview- Douglas Galasko, MD

UCSD Shiley-Marcos ADRC

Open House 2024: Douglas Galasko, MD - New treatments and clinical trials for Alzheimer's Disease

UCSD Shiley-Marcos ADRC

Douglas Galasko, MD - Frontotemporal Lobar Degeneration Research Opportunities

UCSD Shiley-Marcos ADRC

Douglas Galasko, MD-New Treatments and Research for Alzheimer’s Disease and Related Disorders

UCSD Shiley-Marcos ADRC

PCALECTURE with UCSD neurologist Dr, Dougla sGalasko

PCA LECTURE SERIES with host Jamie Talan

Longitudinal approaches to Alzheimer’s studies

Dr. Douglas Galasko speaks to News 8 about new Alzheimer's drug

CBS 8 San Diego

Douglas Galasko, MD - CSF and Blood Biomarkers for Alzheimer's

UCSD Shiley-Marcos ADRC

GR 3 13 2023: Integrative Analysis of Longitudinal Studies on Aging and Dementia.

JABSOM, Geriatric Medicine Webinars

Neurodiversa Introduction

Dementia with Lewy Bodies Workshop: Filling the Gaps in Translational and Clinical Research Day 2

National Institute on Aging

Can you think your way out of dementia? The effect of psychological wellbeing on Alzheimer's D risk.

Douglas Research Centre

Resistance and resilience to Alzheimer's disease

Douglas Research Centre

AADC Smart Talk: Alzheimer's Disease November 2024

Douglass Alumnae

Katherine Bangen, PhD, ABPP-CN-Cerebral Blood Flow & Arterial compliance in Alzheimer's Disease Risk

UCSD Shiley-Marcos ADRC

Geoff Kerchner, MD, PhD: Gantenerumab as Disease-Modifying Treatment in Early Alzheimer Disease

David Wolk, MD: Usefulness of MRI in Alzheimer Disease

The impact of copathologies in Alzheimer's disease

Douglas Research Centre